Abstract
The objective of this study was to systematically identify and meta-analyze randomized controlled trials (RCTs) comparing desflurane and sevoflurane in elderly patients undergoing general anesthesia. Databases including PubMed, EMBASE, Web of Science, and the Cochrane Library were searched through July 2018. Five RCTs involving 324 patients met the inclusion criteria. The analysis revealed that desflurane significantly reduced the time to open eyes (SMD -0.63), follow commands (SMD -0.97), extubation (SMD -0.77), and orientation (SMD -1.49) compared to sevoflurane. However, no significant differences were found regarding total anesthesia time or the length of stay in the postanesthetic care unit (PACU).
Introduction: The Challenge of Geriatric Anesthesia
As global life expectancy increases, the geriatric population requiring surgical intervention is growing. Elderly patients present unique challenges for anesthesiologists due to reduced physiological reserves and a higher risk of delayed recovery or postoperative cognitive dysfunction (POCD). Selecting the optimal anesthetic maintenance agent is therefore crucial. Modern volatile agents like sevoflurane and desflurane are preferred for their low blood solubility, which facilitates rapid emergence. However, clinical evidence comparing the two in elderly populations has been inconsistent. This meta-analysis aims to clarify which agent provides superior efficacy and safety for geriatric patients.
Methodology and Study Selection
The researchers followed standard Cochrane protocols to conduct a systematic review. They identified 658 records initially, which were eventually narrowed down to five high-quality RCTs. Data were analyzed using RevMan 5.2, calculating Standardized Mean Differences (SMD) for continuous outcomes. Heterogeneity was assessed using the $I^2$ statistic, with random-effects models applied where $I^2 > 50\%$.
The final dataset included 324 patients (165 receiving desflurane and 159 receiving sevoflurane) across five international studies: Chen (2001), Iannuzzi (2005), Rortgen (2010), Deepak (2013), and Pakpirom (2016).
Key Results: Faster Emergence with Desflurane
The meta-analysis demonstrated a clear advantage for desflurane in early recovery metrics. Desflurane's lower blood-gas partition coefficient likely explains its faster "wash-out" from the bloodstream, allowing patients to transition from an anesthetized state to wakefulness more rapidly.
Key findings include:
- Time to open eyes: Significantly shorter with desflurane (SMD -0.63; $P=0.04$).
- Following commands: Significantly faster (SMD -0.97; $P=0.01$).
- Extubation time: Significantly faster (SMD -0.77; $P=0.009$).
- Orientation: Significantly faster (SMD -1.49; $P < 0.00001$).
Despite these advantages in immediate emergence, the study found no significant difference in total anesthesia time (SMD -0.10; $P=0.43$) or the length of PACU stay (SMD -4.65; $P=0.11$). This suggests that while desflurane accelerates the initial waking process, it does not necessarily translate to a faster discharge from the recovery unit, which may limit its immediate economic impact on hospital throughput.
Discussion and Limitations
While the results favor desflurane for rapid emergence, several limitations must be considered. The total sample size of 324 patients across five studies is relatively small, limiting the power of subgroup analyses. Furthermore, high heterogeneity was observed in some metrics, likely due to varying clinical protocols and discharge criteria across different countries.
The study also lacked sufficient data to evaluate long-term outcomes such as the incidence of POCD or postoperative nausea and vomiting. Future large-scale, multi-center trials are needed to determine if the early recovery benefits of desflurane lead to improved long-term clinical outcomes or significant cost savings in geriatric care.
Summary updated